Continue with FacebookLooking to list your PhD opportunities? Log in here.
peptide design PhD Projects, Programmes & Scholarships
We have 24 peptide design PhD Projects, Programmes & Scholarships
PhD saved successfully
Design and Engineering of Light-activated Enzymes for Chemicals Production
In this PhD studentship, we will pioneer generalized, rule-based design of photo-biocatalysts to open up new and high-energy catalytic reaction pathways. Read more
Enzyme-responsive peptide hydrogel as in situ forming long-acting drug delivery implants
One of the key issues in the treatment and prevention of disease is that patients struggle to adhere to the complex dosage regimens of therapies, which often require multiple dosing at very specific times each day. Read more
Chromosome substitution strains from Chinese wild mice
Supervisors. Principal supervisor. Professor/Dr Minyan Wang…. (XJTLU). Co-supervisor. Professor/Dr Jing Zhao……...(JITRI). Read more
Structure based design of novel warheads for use in peptide-drug conjugates
Chronic Myelomonocytic Leukaemia (CMML) is an orphan disease defined by myeloid dysplasia, myeloproliferation and a malignant expansion of classical monocytes. Read more
Unlocking the potential of a novel microtubule growth inhibitor as a cancer therapeutic
Microtubules are a functionally versatile and critically important component of the cytoskeleton and as a result have been one of the most actively pursued therapeutic targets of the past 60 years. Read more
Design, synthesis and evaluation of protease-activated anti-cancer prodrugs
Research Group:
Institute of Cancer Therapeutics
Matrix metalloproteinases (MMPs) are a family of endoproteases that are overexpressed in tumours and play crucial roles in many tumourigenic processes, not least tumour invasion and angiogenesis. Read more
Demystifying the activation mechanism of Glucagon-Like Peptide Receptor 1
Coventry University (CU) is inviting applications from suitably-qualified graduates for a fully-funded PhD studentship. The glucagon-like peptide receptor (GLP-1R) is a validated target for type 2 diabetes (T2D). Read more
Development of peptide hydrogel as an anticancer drug carrier
Growth in nanotechnologies can now be exploited to enable engineering of new drug delivery systems for enhancing the entrapment of drugs in nano-sized structures with tailored physical properties to suit therapeutic need. Read more
Demystifying the activation mechanism of Glucagon-Like Peptide Receptor 1
The glucagon-like peptide receptor (GLP-1R) is a validated target for type 2 diabetes (T2D). The structure of GLP-1R and how new potential T2D oral drugs bind are well known. Read more
Design and Synthesis of Metal-Organic Cage Complexes for use as Imaging Labels in Electron Microscopy
Applications are invited for a fully-funded postgraduate studentship at the interface of chemistry and structural biology. The position is available in the Riddell group from September 2023. Read more
Artificial Intelligence algorithms to predict aggregation and gel phenomena in peptide synthesis and isolation
Are you interested in helping to design the next generation of active molecules for applications in industry? Are you looking for a PhD position… Read more
A novel strategy to combat Group B Streptococcus neonatal disease by targeting interkingdom interactions with fungus Candida albicans
Group B Streptococcus (GBS) is a major cause of infant death and morbidity worldwide, resulting in 147,000 stillbirths and infant deaths annually. Read more
Targeting the myosin light chain phosphatase with peptide disruptors: a novel antiplatelet therapeutic approach
If you are interested in platelet biology, haematology, biochemistry and cell biology, this fully-funded British Heart Foundation PhD project is for you. Read more
The design of next-generation synthetic transcriptional activators: a new therapeutic platform for the treatment of triplet expansion diseases
Background – One of the holy grails of genetic medicine is to develop molecular therapies which can correct aberrant gene expression. Read more
Fragment-Based Lead Generation of Small Molecule Inhibitors of the Nsp3 Macrodomain in SARS-CoV-2
Background. Coronaviruses (CoVs) are important human pathogens and SARS-CoV-2 is responsible for the current COVID-19 pandemic. Read more
- 1
- 2